One year outcomes and costs following a vertebral fracture
- 393 Downloads
Vertebral fractures are believed to be important predictors for future vertebral and other fractures, leading to at least a 4- to 5-fold increase in the risk of subsequent fractures. However, little is known about their associated near-term costs. The purpose of this study was to quantify the subsequent fracture and cost outcomes emanating from patients with an incident vertebral fracture. A probabilistic decision analysis model was developed to estimate the expected cost of all subsequent fractures. We ran Kaplan-Meier time-to-event models on placebo patients in risedronate’s pivotal phase III clinical trial data to determine the cumulative incidence or probabilities of all fractures within one year of an incident vertebral fracture. Unit costs for health care payers in the USA and Sweden for vertebral, hip, other, and forearm/wrist fractures were multiplied by fracture probabilities to generate the expected costs of new fractures within one year of incident vertebral fractures. Our analysis found that that 26.1% of vertebral fracture patients with a mean age of 74 years refractured within 1 year (vertebral 17.4%; hip 3.6%; “other” 3.5%; forearm/wrist 1.6%). The calculated medical costs for those patients who refracture within 1 year was $5906 and €3670 for the USA and Sweden, respectively, while the weighted average cost across all patients (refracture and non-fracture) within a year of their incident fracture was $1541 (USA) and €958 (Sweden). These results suggest that therapies with proven, rapid efficacy may offer important economic value to healthcare payers, providers and patients.
KeywordsCosts Osteoporosis Outcomes Refracture Vertebral fractures
This study was supported by the Alliance for Better Bone Health (Aventis Pharma and Procter & Gamble Pharmaceuticals).
Conflict of interest:
No information supplied.
- 1.Ross PD, Davis JW, Epstein RS, Wasnich RD (1991) Pre-existing fractures and bone mass predict vertebral fracture incidence in women. Ann Int Med 114:919–923Google Scholar
- 4.Kotowicz M, Melton LJ, Cooper C, Atkinson EJ, O’Fallon WM, Riggs BL (1994) Risk of hip fracture in women with vertebral fracture. J Bone Miner Res 5:599–605Google Scholar
- 12.Burge RT, Puleo E, Gehlbach S, Worley D, Klar J (2002) Inpatient hospital and post-acute care for vertebral fractures in women. Value-In-Health 5:301–311Google Scholar
- 17.US Congress Office of Technical Assistance (1994) Hip fracture outcomes in people age fifty and over: background paper. US Government Printing Office, Washington, D.C.Google Scholar
- 18.Decision Analysis by TreeAge (DATA), Version 3.5.4. TreeAge Software, Inc. Williamstown, Mass., USAGoogle Scholar
- 19.Harris ST, Watts NB, Genant HK et al. (1999) Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. JAMA 280:2077–2082Google Scholar
- 23.National Osteoporosis Foundation (1998) Osteoporosis: review of the evidence for prevention, diagnosis and treatment and cost-effective analysis. Osteoporos Int Supplement 4:s1–s88Google Scholar
- 24.Nationwide Inpatient Sample, Release 6 (1997) Healthcare Cost and Utilization Project, Agency for Healthcare Research and Quality, Rockville, Maryland, USAGoogle Scholar
- 25.Hoerger T, Downs K, Lakshmanan M et al. (1999) Healthcare use among US women aged 45 and older: total costs and costs for selected postmenopausal health risks. J Women’s Health Gender-Based Med 8:1077–1089Google Scholar
- 29.Holbrook TL et al. (1984) The frequency of occurrence, impact, and cost of selected musculoskeletal conditions in the US. American Academy of Orthopedic Surgeons, ChicagoGoogle Scholar
- 31.Zethraeus N, Borgström F, Johnell O, Kanis J, Önnby K, Jönsson B (2002) Costs and quality of life associated with osteoporosis related fractures—results from a Swedish survey. SSE/EFI Working Paper Series in Economics and Finance, No 512, OctoberGoogle Scholar